Targeted Lipidomics of Fontal Cortex and Plasma Diacylglycerols (DAG) in Mild Cognitive Impairment and Alzheimer's Disease: Validation of DAG Accumulation Early in the Pathophysiology of Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 48, Issue 2, 2015, Pages 537-546

  Wood, Paul L ^a   Medicherla, Srikanth ^a   Sheikh, Naveen ^a   Terry, Bradley ^a   Phillipps, Aaron ^a   Kaye, Jeffrey A ^b   Quinn, Joseph F ^b   Woltjer, Randall L ^b  

^a Lincoln Memorial University   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; diacylglycerols; mild cognitive impairment; monoacylglycerols

Indexed keywords

DIACYLGLYCEROL; MONOACYLGLYCEROL; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; LIPID BRAIN LEVEL; LIPIDOMICS; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; NEUROPATHOLOGY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; VALIDATION STUDY; BLOOD; COGNITIVE DEFECT; FRONTAL LOBE; MENTAL HEALTH; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITIVE DYSFUNCTION; DIGLYCERIDES; FRONTAL LOBE; HUMANS; MENTAL STATUS SCHEDULE; MIDDLE AGED; MONOGLYCERIDES; TANDEM MASS SPECTROMETRY;

EID: 84941276633     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150336     Document Type: Article

References (48)

1. Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, Zucht HD, Pepin D, Zheng W, Tunnicliffe A, Richardson J, Gauthier S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S (2014) Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement 10, 799-807.
2. Wood PL, Phillipps A, Woltjer RL, Kaye JA, Quinn JF (2014) Increased lysophosphatidylethanolamine and diacylglycerol levels in Alzheimer's disease plasma. JSM Alzheimers Dis Relat Dement 1, 1001.
3. González-Domínguez R, García-Barrera T, Gómez-Ariza JL (2015) Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease. Talanta 131, 480-489.
4. Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, Wenk MR, Shui G, Di Paolo G (2012) Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem 287, 2678-2688.
5. Wood PL, Barnette BL, Kaye JA, Quinn JF, Woltjer RL (2015) Non-targeted lipidomics of CSF and frontal cortex gray and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects. Acta Neuropsychiatr, doi: 10.1017/neu.2015.18.
6. Lam SM, Wang Y, Duan X, Wenk MR, Kalaria RN, Chen CP, Lai MK, Shui G (2014) Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia. Neurobiol Aging 35, 2369-2381.
7. Wood PL (2012) Lipidomics of Alzheimer's disease: Current status. Alzheimers Res Ther 4, 5.
8. Carrasco S, Mérida I (2007) Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci 32, 27-36.
9. Shi Y, Cheng D (2009) Beyond triglyceride synthesis: The dynamic functional roles of MGAT and DGAT enzymes in energy metabolism. Am J Physiol Endocrinol Metab 297, E10-E18.
10. Savinainen JR, Saario SM, Laitinen JT (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol (Oxf) 204, 267-276.
11. Brose N, Betz A, Wegmeyer H (2004) Divergent and convergent signaling by the diacylglycerol second messenger pathway in mammals. Curr Opin Neurobiol 14, 328-340.
12. Madani S, Hichami A, Cherkaoui-Malki M, Khan NA (2004) Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation. J Biol Chem 279, 1176-1183.
13. Heimfarth L, Loureiro SO, Reis KP, de Lima BO, Zamboni F, Gandolfi T, Narvaes R, da Rocha JB, Pessoa-Pureur R (2011) Cross-talk among intracellular signaling pathways mediates the diphenyl ditelluride actions on the hippocampal cytoskeleton of young rats. Chem Res Toxicol 24, 1754-1764.
14. Shin J, Xie D, Zhong XP (2013) MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ. PLoS One 8, e77983.
15. Genc O, Kochubey O, Toonen RF, Verhage M, Schneggenburger R (2014) Munc18-1 is a dynamically regulated PKC target during short-term enhancement of transmitter release. Elife 3, e01715.
16. Chauveau A, Le Floc'h A, Bantilan NS, Koretzky GA, Huse M (2014) Diacylglycerol kinase α establishes T cell polarity by shaping diacylglycerol accumulation at the immunological synapse. Sci Signal 7, ra82.
17. Schlam D, Bohdanowicz M, Chatgilialoglu A, Steinberg BE, Ueyama T, Du G, Grinstein S, Fairn GD (2013) Diacylglycerol kinases terminate diacylglycerol signaling during the respiratory burst leading to heterogeneous phagosomal NADPH oxidase activation. J Biol Chem 288, 23090-23104.
18. Sarri E, Sicart A, Lázaro-Diéguez F, Egea G (2011) Phospholipid synthesis participates in the regulation of diacylglycerol required for membrane trafficking at the Golgi complex. J Biol Chem 286, 28632-28643.
19. García del Caño G, Montaña M, Aretxabala X, González-Burguera I, López de Jesús M, Barrondo S, Sallés J (2014) Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons. Adv Biol Regul 54, 12-23.
20. Domart MC, Hobday TM, Peddie CJ, Chung GH, Wang A, Yeh K, Jethwa N, Zhang Q, Wakelam MJ, Woscholski R, Byrne RD, Collinson LM, Poccia DL, Larijani B (2012) Acute manipulation of diacylglycerol reveals roles in nuclear envelope assembly & endoplasmic reticulum morphology. PLoS One 7, e51150.
21. Peddie CJ, Blight K, Wilson E, Melia C, Marrison J, Carzaniga R, Domart MC, O'Toole P, Larijani B, Collinson LM (2014) Correlative and integrated light and electron microscopy of in-resin GFP fluorescence, used to localise diacylglycerol in mammalian cells. Ultramicroscopy 143, 3-14.
22. Wood PL (2014) Mass spectrometry strategies for targeted clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology. Neuropsychopharmacology 39, 24-33.
23. Wood PL, Shirley NR (2013) Lipidomics analysis of postmortem interval: Preliminary evaluation of human skeletal muscle. Metabolomics 3, 3.
24. Wood PL, Bravermann NE (2014) Lipidomics analysis of peroxisomal disorders: Discovery of deficits in phosphatidyglycerol levels in Rhizomelic Chondrodysplasia Type 1. J Data Mining Genomics Proteomics S1, 001.
25. Wood PL (2014) Accumulation of N-acylphosphatidylserines and N-acylserines in the frontal cortex in schizophrenia. Neurotransmitter 1, e263.
26. Schuhmann K, Almeida R, Baumert M, Herzog R, Bornstein SR, Shevchenko A (2012) Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J Mass Spectrom 47, 96-104.
27. Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ (2013) Neuronal dark matter: The emerging role of microRNAs in neurodegeneration. Front Cell Neurosci 7, 178.
28. Mulder J, Zilberter M, Pasquaré SJ, Alpár A, Schulte G, Ferreira SG, Köfalvi A, Martín-Moreno AM, Keimpema E, Tanila H, Watanabe M, Mackie K, Hortobágyi T, de Ceballos ML, Harkany T (2011) Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 134, 1041-1060.
29. Farooqui AA, Liss L, Horrocks LA (1988) Stimulation of lipolytic enzymes in Alzheimer's disease. Ann Neurol 23, 306-308.
30. Shimohama S, Sasaki Y, Fujimoto S, Kamiya S, Taniguchi T, Takenawa T, Kimura J (1998) Phospholipase C isozymes in the human brain and their changes in Alzheimer's disease. Neuroscience 82, 999-1007.
31. Zhang D, Dhillon H, Prasad MR, Markesbery WR (1998) Regional levels of brain phospholipase Cgamma in Alzheimer's disease. Brain Res 811, 161-165.
32. Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S, Jeng AT, Cooper B, Skorupa T, Carrell D, Levitch D, Hsu S, Choi J, Ryten M; UK, Brain Expression Consortium, Hardy J, Ryten M, Trabzuni D, Weale ME, Ramasamy A, Smith C, Sassi C, Bras J, Gibbs JR, Hernandez DG, Lupton MK, Powell J, Forabosco P, Ridge PG, Corcoran CD, Tschanz JT, Norton MC, Munger RG, Schmutz C, Leary M, Demirci FY, Bamne MN, Wang X, Lopez OL, Ganguli M, Medway C, Turton J, Lord J, Braae A, Barber I, Brown K; Alzheimer's Research UK Consortium, Passmore P, Craig D, Johnston J, McGuinness B, Todd S, Heun R, Kölsch H, Kehoe PG, Hooper NM, Vardy ER, Mann DM, Pickering-Brown S, Brown K, Kalsheker N, Lowe J, Morgan K, David Smith A, Wilcock G, Warden D, Holmes C, Pastor P, Lorenzo-Betancor O, Brkanac Z, Scott E, Topol E, Morgan K, Rogaeva E, Singleton AB, Hardy J, Kamboh MI, St George-Hyslop P, Cairns N, Morris JC, Kauwe JS, Goate AM (2014) Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature 505, 550-554.
33. Rosenthal SL, Kamboh MI (2014) Late-onset Alzheimer's disease genes and the potentially implicated pathways. Curr Genet Med Rep 2, 85-101.
34. Chouraki V, Seshadri S (2014) Genetics of Alzheimer's disease. Adv Genet 87, 245-294.
35. Wang J, Yu JT, Tan L (2014) PLD3 in Alzheimer's disease. Mol Neurobiol 51, 480-486.
36. Satoh J, Kino Y, Yamamoto Y, Kawana N, Ishida T, Saito Y, Arima K (2014) PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains. Alzheimers Res Ther 6, 70.
37. Umemura K, Yamashita N, Yu X, Arima K, Asada T, Makifuchi T, Murayama S, Saito Y, Kanamaru K, Goto Y, Kohsaka S, Kanazawa I, Kimura H (2006) Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients. Neurosci Lett 400, 97-100.
38. Cordeiro Q, Noguti R, Bottino CM, Vallada H (2010) Study of association between genetic polymorphisms of phospholipase A2 enzymes and Alzheimer's disease. Arq Neuropsiquiatr 68, 189-193.
39. Martínez-García A, Sastre I, Recuero M, Aldudo J, Vilella E, Mateo I, Sánchez-Juan P, Vargas T, Carro E, Bermejo-Pareja F, Rodríguez-Rodríguez E, Combarros O, Rosich-Estrago M, Frank A, Valdivieso F, Bullido MJ (2010) PLA2G3, a gene involved in oxidative stress induced death, is associated with Alzheimer's disease. J Alzheimers Dis 22, 1181-1187.
40. Gong H, Dong W, Rostad SW, Marcovina SM, Albers JJ, Brunzell JD, Vuletic S (2013) Lipoprotein lipase (LPL) is associated with neurite pathology and its levels are markedly reduced in the dentate gyrus of Alzheimer's disease brains. J Histochem Cytochem 61, 857-868.
41. Wood PL (2003) The cerebellum in AD: A case for arrested neuroinflammation? In Neuroinflammation: Mechanisms and Management, 2nd edition. Wood PL, ed. Humana Press, Totowa, NJ, pp. 295-300.
42. Mead JR, Irvine SA, Ramji DP (2002) Lipoprotein lipase: Structure, function, regulation, and role in disease. J Mol Med (Berl) 80, 753-769.
43. Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC (2014) Metabolic syndrome and longitudinal changes in cognitive function: A systematic review and meta-analysis. J Alzheimers Dis 41, 151-161.
44. Srivastava SP, Shi S, Koya D, Kanasaki K (2014) Lipid mediators in diabetic nephropathy. Fibrogenesis Tissue Repair 7, 12.
45. Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR, Petersen RC, Turner RS, Kukull WA, Bennett DA, Galasko D, Morris JC, Ott J (2011) Alzheimer disease pathology in cognitively healthy elderly: A genomewide study. Neurobiol Aging 32, 2113-2122.
46. Wood PL, Wood JA (2014) Critical assessment of the status of Alzheimer's disease biomarkers. J Parkinsons Dis Alzheimers Dis 1, 4.
47. Brindley DN, Pilquil C, Sariahmetoglu M, Reue K (2009) Phosphatidate degradation: Phosphatidate phosphatases (lipins) and lipid phosphate phosphatases. Biochim Biophys Acta 1791, 956-961.
48. Chen Y, Rui BB, Tang LY, Hu CM (2015) Lipin family proteins - key regulators in lipid metabolism. Ann Nutr Metab 66, 10-18.